Table 3.
Factor | Overall Survival | ||||||
---|---|---|---|---|---|---|---|
Subtype | Cox, p | Logrank, p | Median Survival (Months) | SE | 95% Confidence Interval | ||
Lower | Upper | ||||||
pERK | 0 | 0.006 | 0.008 | 104.0 | 52.4 | 1.3 | 206.6 |
1 | 96.0 | 19.9 | 56.8 | 135.1 | |||
2 | 48.0 | 7.3 | 33.7 | 62.2 | |||
Grade | Low | 0.010 | 0.011 | 86.0 | 16.5 | 53.5 | 118.4 |
mediate | 55.0 | 2.6 | 49.8 | 60.1 | |||
High | 44.0 | 9.1 | 26.0 | 61.9 | |||
Stage | 1 | 0.036 | 0.019 | 58.0 | 10.2 | 37.8 | 78.1 |
2 | 81.0 | 6.7 | 67.6 | 94.3 | |||
3 | 38.0 | 13.5 | 11.3 | 64.6 | |||
4 | 32.0 | 10.7 | 10.8 | 53.1 | |||
Factor | Cancer Specific Survival | ||||||
Subtype | Cox, p | Logrank, p | Median Survival (Months) | SE | 95% Confidence Interval | ||
Lower | Upper | ||||||
pERK | 0 | 0.013 | 0.016 | 104.0 | 52.3 | 1.3 | 206.6 |
1 | 96.0 | 19.9 | 56.8 | 135.1 | |||
2 | 55.0 | 6.3 | 42.5 | 67.4 | |||
pEGFR | 0 | 0.040 | 0.047 | 86.0 | 10.5 | 65.3 | 106.6 |
1 | 62.0 | 9.5 | 43.3 | 80.6 | |||
2 | 48.0 | 9.6 | 29.1 | 66.8 | |||
Grade | Low | 0.011 | 0.012 | 96.0 | 15.9 | 64.7 | 127.2 |
mediate | 77.0 | 13.6 | 50.2 | 103.7 | |||
High | 44.0 | 8.7 | 26.8 | 61.1 | |||
Stage | 1 | 0.042 | 0.039 | 58.0 | 10.2 | 37.8 | 78.1 |
2 | 84.0 | 5.3 | 73.4 | 94.5 | |||
3 | 40.0 | 10.8 | 18.7 | 61.2 | |||
4 | 32.0 | 10.7 | 10.8 | 53.1 |